Cargando…
Deletion of Perilipin 5 Protects against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver diseases with an increasing prevalence due to rising rates of obesity, metabolic syndrome and type II diabetes. Untreated NAFLD may progress to steatohepatitis (NASH) and ultimately liver cirrhosis. NAFLD is characterized b...
Autores principales: | Asimakopoulou, Anastasia, Engel, Kathrin M., Gassler, Nikolaus, Bracht, Thilo, Sitek, Barbara, Buhl, Eva M., Kalampoka, Stavroula, Pinoé-Schmidt, Manuela, van Helden, Josef, Schiller, Jürgen, Weiskirchen, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348929/ https://www.ncbi.nlm.nih.gov/pubmed/32481590 http://dx.doi.org/10.3390/cells9061346 |
Ejemplares similares
-
Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma
por: Asimakopoulou, Anastasia, et al.
Publicado: (2019) -
Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3
por: Schröder, Sarah K., et al.
Publicado: (2022) -
Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019) -
Roles of Perilipins in Diseases and Cancers
por: Zhang, Pengpeng, et al.
Publicado: (2018) -
Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation
por: Cierpka, Rafael, et al.
Publicado: (2021)